betaxolol has been researched along with Obstructive Lung Diseases in 9 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Betaxolol is a new antiglaucomatous drug which is blocking solely the beta 1 receptors and in contrast to Timolol may be applied in persons with spastic conditions of the bronchi." | 9.06 | [Use of Betaxolol in patients with glaucoma and chronic nonspecific diseases of the respiratory system]. ( Rojek, A; Sempińska-Szewczyk, J; Swietliczko, I; Toczyska-Rozentryt, E, 1989) |
| "Betaxolol, a cardioselective beta 1-adrenergic antagonist, was used in a clinical trial in nine patients with glaucoma and chronic obstructive airways disease to assess its patient acceptance, and its effect on intraocular pressure, respiratory function, corneal and tear function." | 9.06 | Betaxolol eye drops as a safe medication to lower intraocular pressure. ( Brooks, AM; Gillies, WE; West, RH, 1987) |
| "Betaxolol is a new antiglaucomatous drug which is blocking solely the beta 1 receptors and in contrast to Timolol may be applied in persons with spastic conditions of the bronchi." | 5.06 | [Use of Betaxolol in patients with glaucoma and chronic nonspecific diseases of the respiratory system]. ( Rojek, A; Sempińska-Szewczyk, J; Swietliczko, I; Toczyska-Rozentryt, E, 1989) |
| "Betaxolol, a cardioselective beta 1-adrenergic antagonist, was used in a clinical trial in nine patients with glaucoma and chronic obstructive airways disease to assess its patient acceptance, and its effect on intraocular pressure, respiratory function, corneal and tear function." | 5.06 | Betaxolol eye drops as a safe medication to lower intraocular pressure. ( Brooks, AM; Gillies, WE; West, RH, 1987) |
| " This study concerned 21 patients: 8 asthmatics and 13 spastic bronchitics, treated over a period of 4 months in a cross-over, double-blind test by 2 cardio-selective beta-blockers (2 months: betaxolol, 2 months atenolol)." | 5.06 | [Long-term beta adrenergic antagonists in spastic bronchopathies]. ( Blaive, B; Lemoigne, F; Lewest, G; Nahon, F, 1988) |
| "We evaluated the effect of betaxolol on the pulmonary function tests of nine patients with glaucoma and chronic obstructive pulmonary disease (COPD) requiring beta-blocker therapy." | 3.67 | Betaxolol in chronic obstructive pulmonary disease. ( Ofner, S; Smith, TJ, 1987) |
| "Propranolol was associated with a documented increase in the degree of bronchial obstruction." | 2.66 | [Effect of different beta-receptor blockers on the respiratory function of patients with chronic obstructive pulmonary disease and arterial hypertension]. ( Dorow, P, 1987) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 8 (88.89) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (11.11) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Waldock, A | 1 |
| Snape, J | 1 |
| Graham, CM | 1 |
| Swietliczko, I | 1 |
| Rojek, A | 1 |
| Sempińska-Szewczyk, J | 1 |
| Toczyska-Rozentryt, E | 1 |
| Brooks, AM | 1 |
| Gillies, WE | 1 |
| West, RH | 1 |
| Bleckmann, H | 2 |
| Dorow, P | 3 |
| Blaive, B | 1 |
| Nahon, F | 1 |
| Lemoigne, F | 1 |
| Lewest, G | 1 |
| Ofner, S | 1 |
| Smith, TJ | 1 |
| Pecori-Giraldi, J | 1 |
| Collini, S | 1 |
| Planner-Terzaghi, A | 1 |
| Arrico, L | 1 |
| Grechi, G | 1 |
7 trials available for betaxolol and Obstructive Lung Diseases
| Article | Year |
|---|---|
Effects of glaucoma medications on the cardiorespiratory and intraocular pressure status of newly diagnosed glaucoma patients.
Topics: Adrenergic alpha-Agonists; Adrenergic beta-Antagonists; Aged; Analysis of Variance; Betaxolol; Blood | 2000 |
[Use of Betaxolol in patients with glaucoma and chronic nonspecific diseases of the respiratory system].
Topics: Aged; Betaxolol; Clinical Trials as Topic; Female; Glaucoma; Humans; Intraocular Pressure; Lung Dise | 1989 |
Betaxolol eye drops as a safe medication to lower intraocular pressure.
Topics: Adrenergic beta-Antagonists; Aged; Aged, 80 and over; Betaxolol; Clinical Trials as Topic; Cornea; F | 1987 |
[Treatment with betaxolol and placebo eyedrops in patients with glaucoma and reactive airway diseases].
Topics: Adrenergic beta-Antagonists; Betaxolol; Bronchial Provocation Tests; Clinical Trials as Topic; Doubl | 1987 |
[Effect of different beta-receptor blockers on the respiratory function of patients with chronic obstructive pulmonary disease and arterial hypertension].
Topics: Adrenergic beta-Antagonists; Adult; Betaxolol; Blood Pressure; Female; Heart Rate; Humans; Hypertens | 1987 |
[Long-term beta adrenergic antagonists in spastic bronchopathies].
Topics: Adrenergic beta-Antagonists; Asthma; Atenolol; Betaxolol; Bronchitis; Drug Evaluation; Drug Toleranc | 1988 |
[Timolol, betaxolol and befunolol in the treatment of glaucoma. Study of their bronchopulmonary effects].
Topics: Adrenergic beta-Antagonists; Adult; Aged; Betaxolol; Clinical Trials as Topic; Female; Forced Expira | 1988 |
2 other studies available for betaxolol and Obstructive Lung Diseases
| Article | Year |
|---|---|
[Locally applied cardioselective beta blocker and histamine provocation in patients with obstructive airway disease].
Topics: Adrenergic beta-Antagonists; Betaxolol; Bronchial Provocation Tests; Forced Expiratory Volume; Glauc | 1987 |
Betaxolol in chronic obstructive pulmonary disease.
Topics: Adrenergic beta-Antagonists; Aged; Betaxolol; Forced Expiratory Volume; Glaucoma; Humans; Intraocula | 1987 |